Sanofi to provide fill/finish services for Moderna COVID-19 vaccine

By The Science Advisory Board staff writers

April 26, 2021 -- Moderna has inked a new agreement with Sanofi in order to scale up U.S. manufacturing capacity for its COVID-19 vaccine.

Beginning in September, Sanofi will provide fill/finish sterile manufacturing services and supply packaging for up to 200 million doses of Moderna's COVID-19 vaccine in the U.S., according to Moderna. Sanofi will utilize manufacturing infrastructure at its location in Ridgefield, NJ.


Copyright © 2021 scienceboard.net
 


MemberID or email address:  

Password:  
Forgot your password?